Survey Data Reports

The "Ophthalmic Market Trends: Quarterly US Cataract Editions" provide a timely, data-driven view of the US cataract surgery market based on ongoing surveys of practicing cataract surgeons. Published four times per year, these reports deliver an accurate assessment of current market conditions, helping manufacturers, investors, analysts, and industry stakeholders understand how the market is evolving and where opportunities are emerging.

Each edition tracks key clinical, procedural, and technology adoption trends, offering insights into surgeon preferences, product utilization, purchasing intentions, and competitive market dynamics. By combining current survey results with historical trend analysis, the reports identify meaningful shifts in cataract surgery practice patterns and technology adoption as they occur.

The "Ophthalmic Market Trends: Quarterly US Refractive Editions" provide a comprehensive view of the US refractive surgery market through quarterly surveys of practicing refractive surgeons. Designed to capture changes as they happen, these reports deliver timely insights into procedure demand, technology utilization, surgeon preferences, and evolving patient care trends.

Each edition examines the key drivers shaping the refractive market, from LASIK and surface ablation volumes to the adoption of emerging technologies and treatments. The reports combine current market intelligence with historical trend data to help readers understand where the market stands today and where it is headed next.

The "Ophthalmic Market Trends: Quarterly US Glaucoma Editions" deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

The Ophthalmic Market Trends: Quarterly US Retina Editions offer in-depth, quarterly insights into the ever-evolving US retina market. By surveying retina specialists and analyzing key metrics, these reports provide valuable data on retinal patient care, product usage, market share, and emerging trends. Each edition covers critical aspects such as IVT injections, DME treatments, vitrectomy volumes, and the adoption of both surgical equipment and pharmaceuticals like Eylea, Lucentis, and Avastin. With detailed trend analysis, full-year forecasts, and year-over-year comparisons, these editions are essential for making informed decisions and staying ahead in the retina care market.

Market Scope’s "2026 United States Cataract Surgeon Survey Report" provides an in-depth look at the current state and future direction of the US cataract surgery market. Based on responses from 115 cataract surgeons representing more than 1,000 practitioners across a wide range of practice settings, the report delivers actionable insights into surgeon preferences, technology adoption, and evolving market dynamics.

The survey examines practice characteristics, surgical techniques, product utilization, patient education and marketing strategies, and purchasing behavior. Expanded coverage explores premium cataract surgery trends, including presbyopia-correcting, toric, enhanced monofocal, and EDOF IOL adoption, astigmatism management, femtosecond laser-assisted cataract surgery (FLACS), surgical site trends, patient financing, and interest in emerging technologies and equipment.

The report also provides detailed market share analysis by manufacturer, brand, and product category, offering a clear view of the competitive landscape across IOLs, phaco systems, viscoelastics, intraoperative pharmaceuticals, MIGS devices, and other key cataract surgery products. Additional sections examine glaucoma co-management patterns, MIGS utilization, and surgeon perspectives on future market developments.

Designed for manufacturers, investors, and industry stakeholders, this report combines surgeon-reported data with expert analysis to deliver a comprehensive view of the trends shaping the US cataract market, making it an essential resource for strategic planning, product development, and competitive intelligence.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Survey Report” provides a data-driven snapshot of how United States ophthalmologists and optometrists are evaluating, purchasing, and using diagnostic technologies in today’s evolving clinical environment.  

Based on a nationwide online survey of 480 verified providers, the report delivers direct insight into capital investment priorities, technology adoption, and the growing influence of digital tools, AI, and data integration across ophthalmic practices.  

This survey report examines how and why purchasing decisions are made, what features and services matter most, how diagnostic budgets are changing, and where practices see value in next-generation technologies. Coverage spans core diagnostic categories as well as fast-growing areas such as artificial intelligence, interoperability, digital applications, and telehealth—offering both a current-state assessment and a forward-looking view of the diagnostic landscape. 

Survey questions were developed by Market Scope in collaboration with sponsoring companies, ensuring the data addresses the most commercially and strategically relevant issues facing diagnostic equipment manufacturers.  

Market Scope’s “2025 Myopia Management Survey Report” delivers a comprehensive, provider-level view of how pediatric myopia is being managed in the United States today—examining patient volumes, treatment mix, economics, unmet needs, and how clinical behavior is likely to shift as new therapies reach the market. 

Conducted in August and September 2025, the survey captures insights from 150 US-based optometrists and ophthalmologists, including comprehensive and pediatric specialists actively treating myopia. Respondents were drawn from Market Scope’s self-registered provider community and reflect real-world clinical decision-makers with direct experience in myopia control. 

The report provides a structured summary analysis of de-identified survey data, calculated at the respondent level and presented without market extrapolation to clearly show how providers are thinking, prescribing, pricing, and planning. 

Market Scope surveyed ophthalmologists and optometrists in the US and Western Europe (WE) during July and August 2025 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends. 

Ophthalmologists and optometrists from most specialties (cataract, refractive, retina, dry eye glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in the annual sponsored survey. 

An email invitation was sent on July 25, 2025, and a last call went out on Aug. 8, 2025. We received 198 total complete, unique responses—158 from the US and 40 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey. 

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server. 

Market Scope's first-edition "2025 Presbyopia Survey Report" provides pivotal insights into treatment methods, adoption plans, average pricing, and emerging technologies shaping the presbyopia landscape. From drops to presbyopia-correcting IOLs, this report delivers survey data essential for informed decision-making in ophthalmic care. Whether you're a healthcare provider, researcher, or investor, leverage this report to navigate the evolving presbyopia market with confidence. 

Market Scope surveyed US ophthalmic surgeons during March and April 2022 to measure perceptions of practice patterns, product market share, and plans for the coming year. We received 119 responses from doctors performing cataract procedures, representing over one thousand total doctors in single doctor and group practices.

We have conducted annual surveys of US cataract surgeons on important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing since 2001. This survey highlights practice patterns regarding presbyopic-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), sugical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma survery (MIGS) devices and much more. It measures market share by manufacturer, product, and market segment. Leading ophthalmic firms and organizations sponsor the survey in order to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends.